Androgens in Patients With Luminal B and HER2 Breast Cancer Might Be a Biomarker Promoting Anti-PD-1 Efficacy

Endocrine therapy is considered as an effective strategy for estrogen and progestogen receptor (ER and PR)-positive breast cancer (BRCA) patients, whereas resistance to these agents is the major cause of BRCA mortality in women. Immune checkpoint receptor (ICR) blockade is another approach to treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Peng, Yuan, Wenhui, Wu, Ruan, Zeng, Chuqian, Li, Ke, Lu, Ligong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307975/
https://www.ncbi.nlm.nih.gov/pubmed/35880165
http://dx.doi.org/10.3389/fonc.2022.917400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307975/
https://www.ncbi.nlm.nih.gov/pubmed/35880165
http://dx.doi.org/10.3389/fonc.2022.917400

Ejemplares similares